Head-to-head · Value Score
RxSpan MD vs Mint Med
Two GLP-1 deals, scored on the same six factors. RxSpan MD lands a Value Score of 86, Mint Med a 87. Here's what each one really costs past month one — and where each one bites back.
RxSpan MD
Grade A- · Great Deal
Advertised price
$249/mo month-to-month
$249/mo month-to-month (as low as $175/mo on the 12-month plan)
Mint Med
Grade A- · Great Deal
Advertised price
$106/mo
$106/mo (all doses)
Save ~70% vs brand self-payThe verdict
Mint Med takes it on Value Score, 87 to 86 — an est. $106/mo (all doses) first month, with no teaser step-up baked in. RxSpan MD isn't out of it: People who want a wide, doctor-fronted menu with all-inclusive pricing and nationwide coverage, and who will budget against the month-to-month figure rather than the advertised one.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | RxSpan MD | Mint Med |
|---|---|---|
| Value Score | 86 (A-) | 87 (A-) |
| Advertised price | $249/mo month-to-month (as low as $175/mo on the 12-month plan) | $106/mo (all doses) |
| Save vs brand self-pay | — | ~70% |
| Semaglutide | $249/mo month-to-month (as low as $175/mo on the 12-month plan) | $106/mo (all doses) |
| Tirzepatide | $329/mo month-to-month (as low as $243/mo) | From $145/mo |
| Both molecules | Yes | Yes |
| Pricing | Watch | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
RxSpan MD
A broad, physician-led menu - compounded and oral GLP-1 plus an advertised brand-name lane under a named plastic surgeon - priced at $249 a month for semaglutide, with the advertised low rates attached to a plan.
What's good
- Available in all 50 states
- Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support in one price; cancel or change plans anytime, with the card advertising as low as $175/mo on compounded semaglutide for anyone who commits to a plan
- Both injectable and a real oral (capsule) route, on compounded sema/tirz plus an advertised brand-name lane
- Physician-led by a named, board-certified founder (Dr. John Diaz, plastic surgeon); 24/7 unlimited messaging and coaching, free shipping
The fine print
- Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy, Ozempic or Zepbound
- RxSpan MD's brand-name lane is expensive: $1,069 for a first month of Zepbound, $1,299 for Ozempic and $1,349 for Wegovy
- RxSpan MD's $175 and $243 rates need a 12-month plan paid up front with a promo code, and that plan auto-renews
- Prescription isn't guaranteed at RxSpan MD — a provider reviews eligibility after checkout
Mint Med
One price at every semaglutide dose, $106 a month, with the seller stating plainly that there are no membership fees - which is rarer than it should be at this end of the market.
Why it's a deal
- Semaglutide is $106 at every dose, so titrating up does not raise the bill
- States in its own banner that there are no membership fees
- Prices are confirmed in the store's own catalog, not just the marketing page
- HSA and FSA eligible, with a phone number published for support
The fine print
- Tirzepatide is sold as two separate products at $145 and $179, so which one applies depends on the dose you are prescribed
- FDA issued a warning letter to Glow Medispa, LLC dba Mint Med, dated June 2026. It is public in the FDA warning-letter database and linked from this review so you can read it yourself
- Sells NAD+, sermorelin and sexual-wellness lines beside the GLP-1s
- Compounded only, with no brand-name option
- No oral or sublingual route
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores RxSpan MD is ranked on the RxSpan MD alternatives ranking, and the same list for the other side is on alternatives to Mint Med.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.